@FierceMedDev: ICYMI: Researchers develop needle-free temporary tattoo for glucose monitoring. Article | Follow @FierceMedDev
@VarunSaxena2: Piramal buys Coldstream - The Hindu. More | Follow @VarunSaxena2
@EmilyWFierce: Carmat notches a win as artificial heart patient returns home. More | Follow @EmilyWFierce
> GE Healthcare ($GE) has partnered with Volpara Solutions to distribute its dense breast cancer screening tools. Financial terms of the deal were undisclosed. Release
> The U.S. Army and Helius Medical Technologies modified their 2013 Cooperative Research and Development Agreement (CRADA) to help speed the development of a noninvasive brain stimulation device that is being developed for the treatment of balance disorder in patients with mild-to-moderate traumatic brain injury. Release
> FEops, which creates patient-specific 3-D simulations for cardiovascular interventions, got a €1.3 million Series A financing round, led by Capricorn Venture Partners and PMV. Its first product, TAVIguide, is a cloud-based preoperative planning service for transcatheter aortic valve implantation. Release
> Gecko BioMedical got a €1.3 million from Bpifrance to support the development of its biodegradable surgical glues and patches for wound closure. Release
Biotech News
@FierceBiotech: ICYMI: Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms. Report | Follow @FierceBiotech
@JohnCFierce: Alzheimer's investigators open a new front in BACE1 war. More from FierceBiotechResearch | Follow @JohnCFierce
@DamianFierce: A CF patient taking $VRTX's Kalydeco will be a guest of Michelle Obama at the State of the Union tonight. More | Follow @DamianFierce
> Actavis, Richter tout new PhIII data for their tarnished schizophrenia drug. Article
> CytRx surges after FDA lifts a partial hold on late-stage cancer drug. Story
Pharma News
@FiercePharma: MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report from FierceVaccines | Follow @FiercePharma
@CarlyHFierce: ICYMI: Actavis working to add Allergan CEO Pyott to board: Reuters. Story | Follow @CarlyHFierce
> J&J's pharma unit 'fastest-growing' in the drug business, CEO Gorsky says. Report
> GlaxoSmithKline rejected e-cig buy to beef up stop-smoking franchise. Article
Biotech IT News
> Personalis raises $33M to scale up pharma-facing genomics operation. Report
> 10X Genomics exits stealth mode with $80M, plan to improve Illumina tech. News
> Novartis teams with Qualcomm on $100M digital health fund. Item
> Genentech teams with Venter's HLI as Roche group continues genomics push. Story
> 23andMe inks Pfizer deal, eyes 2015 resolution of FDA dispute. Article
CRO News
> Clinipace banks $50M to scout for more deals. Story
> Evotec strikes an R&D deal focused on addiction. More
> AMRI inks a 10-year NIH deal with $37M on the line. News
> Ergomed posts a big year with more in store for 2015. Article
> Sanofi taps Catalent for antibody R&D. Report
Animal Health News
> Annual sales of animal health products stable at $7.5B. Item
> China bans import of U.S. poultry products on avian flu fear. Report
> Microbiome dealmaking hits animal health with Metanome-Companion PBx linkup. More
> PetMed's sales fall but profit margins expand on rising demand for pricier products. Story
> Zoetis, IDEXX, Schein among animal health scene-stealers at JP Morgan confab. Article
Biotech Research News
> Genetic error highlights a new approach to Fragile X syndrome. Report
> Microbiome research opens a new pathway for autoimmune disease. Article
> Tracking tech illuminates T cells for immuno-oncology research. Item
> Michigan investigators finger ATDC gene for aggressive pancreatic cancer. Story
> Alzheimer's investigators open a new front in BACE1 war. More
Pharma Manufacturing News
> Actavis recalling 65,000 bottles of generic seizure drug. News
> FDA raises issues with another Apotex plant. Article
> India makes move to reduce reliance on Chinese APIs. Item
> Boehringer Ingelheim picks up contract work for Sanofi mAbs. News
> India's Piramal says it will snatch up university CDMO for its injectables skills. Report